Exclusive: KPMG partners face court contempt over China audit

Reuters  |  BEIJING 

By Matthew Miller

(Reuters) - Several current and former KPMG partners are facing contempt proceedings in a court, as liquidators for a failed U.S.-listed Chinese company step up their action against the auditor over its refusal to produce Chinese working

The contempt summons, seen by Reuters, names 91 individuals and was issued on Nov. 22. It is the latest move in a battle surrounding the 2012 collapse of Medical Technologies, whose founders are being prosecuted in the for allegedly defrauding investors out of more than $400 million.

The writ highlights a long-running tussle between China, which is reluctant to hand over mainland documents, and overseas regulators that demand such - leaving auditors trapped between upsetting or facing offshore penalties when dealing with foreign-listed Chinese firms.

KPMG was ordered by Hong Kong's High in 2016 to give papers, correspondence and records on Medical to Borrelli Walsh, liquidators for the one-time NASDAQ-listed firm.

But KPMG has refused to do so without written direction of the relevant Chinese authority, arguing that its mainland-based affiliate KPMG Huazhen, which carried out the Medical field work, would be in violation of national security laws if the materials held state secrets or sensitive information, documents and the writ show.

KPMG and Borrelli Walsh both declined to comment.

Those named in the writ were partners in KPMG - the partnership covering China, and - in 2015, which is when the dispute over the began.

Petitions to wind up Medical were filed in the Cayman Islands, and finally in in 2012, and the company was placed into liquidation.

The liquidators are asking each of the 91 defendants be held in contempt of court, which could result in criminal penalties, or impose weekly fines for failure to comply with the High order.

Medical is the most high-profile international contest over Chinese since 2014, when EY, KPMG's fellow Big Four accounting firm, handed over certain documents to Hong after a battle.

EY had argued that Chinese officials would not let it produce documents related to its work on an unfinished of - a Chinese municipal water services provider that scrapped plans for an initial public offering in

A ROCK AND A HARD PLACE

and U.S. regulators have been at loggerheads with Chinese firms and their auditors over the production of work since the start of the decade - a battle that at one point threatened to leave U.S.-listed Chinese groups unaudited and in danger of delisting.

While U.S. and Chinese regulators came to a non-binding agreement in 2013 over exchanging documents, mainland officials have objected to inspections and are still in practice often reluctant to let leave

"The problem for accounting firms is that they're still between a rock and a hard place," said Paul Gillis, at Peking University's Guanghua

"They need to comply with the laws in all of the locations where they are doing business."

In July, the U.S. regulator revoked the registration of the affiliate of because it failed to comply with demands to produce documents, including Chinese work

Earlier in the year, the charged Medical and with securities fraud and wire fraud conspiracy, alleging they stole much of the $426 million they raised in two convertible bond offerings in 2008 and 2010.

KPMG issued written reports for Medical from 2003 to 2008, and was replaced by PwC Zhong Tian in August 2009.

Contempt proceedings will be held at High

(Reporting By Matthew Miller; Editing by and Himani Sarkar)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, December 20 2017. 16:26 IST